Renal cell carcinoma: Evolving and emerging subtypes

doi:10.12998/wjcc.v1.i9.262

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11629)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-10) series, Tables (1-1) series.

Item

Count

PDF

733

HTML

8131

Figures (1-10)

404

Tables (1-1)

182

Sum=9450

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1215

Download

964

Sum=2179

Dec 16, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Dec 16, 2013; 1(9): 262-275
Published online Dec 16, 2013. doi: 10.12998/wjcc.v1.i9.262

Renal cell carcinoma: Evolving and emerging subtypes

Suzanne M Crumley, Mukul Divatia, Luan Truong, Steven Shen, Alberto G Ayala, Jae Y Ro

Suzanne M Crumley, Mukul Divatia, Luan Truong, Steven Shen, Alberto G Ayala, Jae Y Ro, Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Cornell Medical College of Cornell University, Houston, TX 77030, United States

Author contributions: Crumley SM and Divatia M contributed equally to the writing of the text and revisions of the manuscript; Truong L contributed to the revisions and some of the photographs in the figures; Shen S and Ayala AG contributed to the revisions and editing of the manuscript; Ro JY contributed to the conception and revisions of the manuscript.

Correspondence to: Jae Y Ro, MD, PhD, Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Cornell Medical College of Cornell University, 6565 Fannin Street, Suite M227, Houston, TX 77030, United States. jaero@tmhs.org

Telephone: +1-713-4412263 Fax: +1-972-6974622

Received: September 17, 2013
Revised: November 3, 2013
Accepted: December 9, 2013
Published online: December 16, 2013

Core Tip

Core tip: New concepts in selected renal cell carcinoma (RCC) subtypes are reviewed. We describe evolving concepts in Xp11 translocation carcinoma, mucinous tubular and spindle cell carcinoma, multilocular cystic clear cell RCC, and carcinoma associated with neuroblastoma. Additionally, tubulocystic carcinoma, thyroid-like follicular carcinoma of kidney, acquired cystic disease-associated RCC, and clear cell papillary RCC are described. Finally, candidate entities, including RCC with t(6;11) translocation, hybrid oncocytoma/chromophobe RCC, hereditary leiomyomatosis and RCC syndrome, and renal angiomyoadenomatous tumor are discussed. This review provides a targeted summary of recent updates for those who diagnose and treat renal cancer.